UY36221A - Derivados de isoindolinona - Google Patents
Derivados de isoindolinonaInfo
- Publication number
- UY36221A UY36221A UY0001036221A UY36221A UY36221A UY 36221 A UY36221 A UY 36221A UY 0001036221 A UY0001036221 A UY 0001036221A UY 36221 A UY36221 A UY 36221A UY 36221 A UY36221 A UY 36221A
- Authority
- UY
- Uruguay
- Prior art keywords
- isoindolinone derivatives
- isoindolinone
- derivatives
- compounds
- compositions
- Prior art date
Links
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical class C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se dan a conocer compuestos de la fórmula I y métodos para el tratamiento de infecciones virales con composiciones que comprenden estos compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462027359P | 2014-07-22 | 2014-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY36221A true UY36221A (es) | 2016-02-29 |
Family
ID=53718075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001036221A UY36221A (es) | 2014-07-22 | 2015-07-20 | Derivados de isoindolinona |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10118894B2 (es) |
| EP (1) | EP3172200B1 (es) |
| JP (1) | JP2017521458A (es) |
| KR (1) | KR20170032338A (es) |
| CN (1) | CN106536513A (es) |
| AR (1) | AR101255A1 (es) |
| AU (1) | AU2015293506B2 (es) |
| CA (1) | CA2954733A1 (es) |
| CL (1) | CL2017000152A1 (es) |
| ES (1) | ES2703352T3 (es) |
| IL (1) | IL249581A0 (es) |
| PT (1) | PT3172200T (es) |
| RU (1) | RU2017103656A (es) |
| TW (1) | TW201617315A (es) |
| UY (1) | UY36221A (es) |
| WO (1) | WO2016012930A1 (es) |
| ZA (1) | ZA201608511B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015174511A1 (ja) | 2014-05-16 | 2015-11-19 | 塩野義製薬株式会社 | Ｈｉｖ複製阻害作用を有する３環性複素環誘導体 |
| SG11201709634QA (en) | 2015-05-29 | 2017-12-28 | Shionogi & Co | Nitrogen-containing tricyclic derivative having hiv replication inhibitory activity |
| WO2018020357A1 (en) | 2016-07-25 | 2018-02-01 | Viiv Healthcare Uk Limited | Indoline derivatives |
| WO2020102198A1 (en) | 2018-11-13 | 2020-05-22 | Incyte Corporation | Heterocyclic derivatives as pi3k inhibitors |
| WO2020102216A1 (en) | 2018-11-13 | 2020-05-22 | Incyte Corporation | Substituted heterocyclic derivatives as pi3k inhibitors |
| WO2020102150A1 (en) | 2018-11-13 | 2020-05-22 | Incyte Corporation | Heterocyclic derivatives as pi3k inhibitors |
| CA3210209A1 (en) * | 2021-03-03 | 2022-09-09 | The Curators Of The University Of Missouri | Suppression of covid-19 replication by covid-19 entry inhibitors |
| CN115160211B (zh) * | 2022-06-23 | 2023-11-03 | 温州大学 | 一种异吲哚啉酮类化合物的绿色合成方法 |
| KR20240049492A (ko) | 2022-10-08 | 2024-04-16 | 임서윤 | 문어발 건조대 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009026248A2 (en) | 2007-08-17 | 2009-02-26 | The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer | Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| NZ585226A (en) | 2007-11-16 | 2012-08-31 | Gilead Sciences Inc | Inhibitors of human immunodeficiency virus replication |
| EP2511273B8 (en) * | 2011-04-15 | 2019-06-26 | Hivih | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| US8609653B2 (en) | 2011-07-15 | 2013-12-17 | Glaxosmithkline Llc | Azaindole compounds and methods for treating HIV |
| WO2013016441A1 (en) * | 2011-07-26 | 2013-01-31 | The United States of America, represented by The Secretary, Department of Health & Human Services | Hiv integrase inhibitory oxoisoindoline sulfonamides |
| WO2013103738A1 (en) * | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | Napthalene acetic acid derivatives against hiv infection |
| US9006235B2 (en) * | 2012-03-06 | 2015-04-14 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
| CN105121418A (zh) * | 2012-04-20 | 2015-12-02 | 吉利德科学公司 | 苯并噻唑-6-基乙酸衍生物及其治疗hiv感染的用途 |
| PT2877468T (pt) * | 2012-07-12 | 2017-11-21 | Viiv Healthcare Uk Ltd | Compostos e métodos para o tratamento de vih |
-
2015
- 2015-07-20 WO PCT/IB2015/055489 patent/WO2016012930A1/en not_active Ceased
- 2015-07-20 AR ARP150102292A patent/AR101255A1/es unknown
- 2015-07-20 RU RU2017103656A patent/RU2017103656A/ru not_active Application Discontinuation
- 2015-07-20 ES ES15741368T patent/ES2703352T3/es active Active
- 2015-07-20 CA CA2954733A patent/CA2954733A1/en not_active Abandoned
- 2015-07-20 US US15/326,100 patent/US10118894B2/en not_active Expired - Fee Related
- 2015-07-20 TW TW104123444A patent/TW201617315A/zh unknown
- 2015-07-20 CN CN201580039461.2A patent/CN106536513A/zh active Pending
- 2015-07-20 EP EP15741368.3A patent/EP3172200B1/en active Active
- 2015-07-20 UY UY0001036221A patent/UY36221A/es not_active Application Discontinuation
- 2015-07-20 PT PT15741368T patent/PT3172200T/pt unknown
- 2015-07-20 AU AU2015293506A patent/AU2015293506B2/en not_active Ceased
- 2015-07-20 JP JP2017503591A patent/JP2017521458A/ja active Pending
- 2015-07-20 KR KR1020177003010A patent/KR20170032338A/ko not_active Withdrawn
-
2016
- 2016-12-09 ZA ZA2016/08511A patent/ZA201608511B/en unknown
- 2016-12-15 IL IL249581A patent/IL249581A0/en unknown
-
2017
- 2017-01-19 CL CL2017000152A patent/CL2017000152A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2954733A1 (en) | 2016-01-28 |
| JP2017521458A (ja) | 2017-08-03 |
| US20170204058A1 (en) | 2017-07-20 |
| ES2703352T3 (es) | 2019-03-08 |
| RU2017103656A (ru) | 2018-08-22 |
| KR20170032338A (ko) | 2017-03-22 |
| AU2015293506A1 (en) | 2017-01-12 |
| ZA201608511B (en) | 2019-06-26 |
| WO2016012930A1 (en) | 2016-01-28 |
| IL249581A0 (en) | 2017-02-28 |
| CL2017000152A1 (es) | 2017-07-28 |
| RU2017103656A3 (es) | 2018-11-07 |
| CN106536513A (zh) | 2017-03-22 |
| AU2015293506B2 (en) | 2017-08-17 |
| AR101255A1 (es) | 2016-12-07 |
| PT3172200T (pt) | 2019-01-17 |
| US10118894B2 (en) | 2018-11-06 |
| EP3172200B1 (en) | 2018-10-17 |
| EP3172200A1 (en) | 2017-05-31 |
| TW201617315A (zh) | 2016-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280459A (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| CR20170005A (es) | Derivados de insoindolina | |
| MX2022009148A (es) | Composiciones y metodos para el tratamiento de hemoglobinopatias. | |
| UY36221A (es) | Derivados de isoindolinona | |
| BR112017007636A2 (pt) | métodos para a preparação de ribosídeos | |
| MX2017008720A (es) | Derivados y metodos para tratamiento de las infecciones por hepatitis b. | |
| EA201891211A1 (ru) | Ингибиторы cxcr2 | |
| CL2016003398A1 (es) | Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo. | |
| PH12017500207A1 (en) | Indoles for use in influenza virus infection | |
| DK3119762T3 (da) | Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft | |
| CL2014001956A1 (es) | Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas. | |
| CL2015002855A1 (es) | Derivados de oxopiridina sustituida. | |
| CL2016002157A1 (es) | Anticuerpos anti-cd38 para el tratamiento de leucemia linfoide aguda | |
| CL2016002255A1 (es) | Inhibidores de c5a para el tratamiento de la neumonía viral | |
| EA201790571A1 (ru) | Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа | |
| EP3360010A4 (en) | BI PHOTONS WITH VOTABLE SOURCE | |
| MX2017001352A (es) | Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2). | |
| LT3436074T (lt) | Tiazolido junginiai, skirti virusinių infekcijų gydymui | |
| MX2017011655A (es) | Compuestos de aza-piridona y usos de estos. | |
| CL2017000151A1 (es) | Derivados de piridona | |
| HUE058802T2 (hu) | RIPK1 inhibitorokként alkalmas vegyületek | |
| CR20160448A (es) | Nuevos derivados de piridina | |
| HUE042043T2 (hu) | Malária megelõzésére vagy kezelésére alkalmas triaminopiridin-vegyületek | |
| MX369857B (es) | Pirazinas moduladoras de receptor 6 acoplado a la proteina g (gpr6). | |
| CL2015003431A1 (es) | Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20220705 |